
[Medical Today Reporter Choi Min-seok] PRODIZEN, a company specializing in medical devices for regenerative medicine, showcased the global competitiveness of Korea’s regenerative medicine technology by conducting an international technology exchange program with its WORLD PRP partner.
The program was organized to share Korea’s advanced PRP technology and clinical experience and further strengthen global partnerships. Through the “K-Beauty Global Medical Seminar,” PRODIZEN introduced Korea’s regenerative medicine technologies and clinical applications while continuing its technical exchanges with overseas partners.
At Olijun Clinic, participants attended a Clinical Experience Program where they observed actual PRP treatment protocols and various clinical applications, gaining insights into the expertise and clinical experience of Korean healthcare professionals.
The program continued at PRODIZEN, where the company introduced its PRP-related equipment and products to enhance participants’ technical understanding. The participants also exchanged views on the products’ key features, potential applications, and future areas of cooperation.
The program was particularly meaningful because it went beyond a conventional product presentation, enabling participants to directly share Korea’s regenerative medicine technologies and clinical experience while further strengthening the foundation for cooperation among global partners. It also provided an opportunity to highlight the excellence of Korea’s K-Beauty-based regenerative medicine technology and explore its potential for expansion in the global market.
A PRODIZEN representative said, “Sharing technology and clinical experience is particularly important in the regenerative medicine field. We will continue to demonstrate the competitiveness of Korea’s regenerative medicine technology worldwide and expand global cooperation through ongoing technical exchanges with our international partners.”
PRODIZEN plans to continue expanding its cooperation with healthcare professionals and partners worldwide while contributing to the advancement of regenerative medicine and strengthening its global network through innovative PRP solutions.
Medical Today Reporter Choi Min-seok (biz@mdtoday.co.kr)